(MedPage Today) — In January 2025, we reported about an observational study of nearly 2 million U.S. military veterans that showed a broad spectrum of possible risks and benefits associated with GLP-1 receptor agonists. In this report, we follow…
Source:
Read full article at www.medpagetoday.com
Medical Disclaimer:
This content is for informational and educational purposes only.
It does not replace professional medical advice.













